The RevolveSD Series, developed by the Downers Grove-based manufacturer, utilizes a durable polyphenylsulfone construction that withstands the harsh chemicals often found in antibody drug conjugate manufacturing. By incorporating a metal-free, dual-valve design, the system minimizes residual fluid on external surfaces and ensures a smooth, bidirectional flow, which prevents the turbulence often associated with restrictive valve architectures.

Spencer Juola, product manager at CPC Biotech, noted that the system serves as a definitive one-time disconnect, preventing the risks associated with unintended reconnection. The product builds on the company’s existing AseptiQuik technology, aiming to simplify teardown complexities for large-scale facilities. By removing the requirement for external sealing tools, the device allows for rapid, secure fluid management, catering to the industry’s demand for high-flow, single-use efficiency.